Fingerprint
Dive into the research topics of 'The US Food and Drug Administration's use of pathologic complete response as regulatory endpoint: Did it pay off?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The US Food and Drug Administration's use of pathologic complete response as regulatory endpoint: Did it pay off?
Jia Luo, Vinay Prasad
Research output: Contribution to journal › Article › peer-review